» Articles » PMID: 17190945

Herbicide Exposure Modifies GSTP1 Haplotype Association to Parkinson Onset Age: the GenePD Study

Abstract

Background: Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the GenePD Study sample of familial PD cases, we explored whether GSTP1 polymorphisms were associated with the age at onset of PD symptoms and whether that relation was modified by exposure to herbicides.

Methods: Seven single-nucleotide polymorphisms (SNPs) were genotyped and tested for association with PD onset age in men in three strata: no exposure to herbicides, residential exposure to herbicides, and occupational exposure to herbicides. Haplotypes were similarly evaluated in stratified analyses.

Results: Three SNPs were associated with PD onset age in the group of men occupationally exposed to herbicides. Three additional SNPs had significant trends for the association of PD onset age across the herbicide exposure groups. Haplotype results also provided evidence that the relation between GSTP1 and onset age is modified by herbicide exposure. One haplotype was associated with an approximately 8-years-earlier onset in the occupationally exposed group and a 2.8-years-later onset in the nonexposed group.

Conclusions: Herbicide exposure may be an effect modifier of the relation between glutathione S-transferase pi gene polymorphisms and onset age in familial PD.

Citing Articles

Sex and gender differences in the molecular etiology of Parkinson's disease: considerations for study design and data analysis.

Schaffner S, Tosefsky K, Inskter A, Appel-Cresswell S, Schulze-Hentrich J Biol Sex Differ. 2025; 16(1):7.

PMID: 39901234 PMC: 11789417. DOI: 10.1186/s13293-025-00692-w.


Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.

Schaffner S, Casazza W, Artaud F, Konwar C, Merrill S, Domenighetti C NPJ Parkinsons Dis. 2024; 10(1):98.

PMID: 38714693 PMC: 11076573. DOI: 10.1038/s41531-024-00704-3.


Incidence of Parkinson disease in North America.

Willis A, Roberts E, Beck J, Fiske B, Ross W, Savica R NPJ Parkinsons Dis. 2022; 8(1):170.

PMID: 36522332 PMC: 9755252. DOI: 10.1038/s41531-022-00410-y.


Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.

Angelopoulou E, Paudel Y, Papageorgiou S, Piperi C Brain Sci. 2022; 12(2).

PMID: 35203939 PMC: 8870303. DOI: 10.3390/brainsci12020175.


In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid.

Crawford R, Bowman K, Cagle B, Doorn J Neurotoxicology. 2021; 86:85-93.

PMID: 34314733 PMC: 8440459. DOI: 10.1016/j.neuro.2021.07.005.